Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
New Engl J Med (2022) 387(3):20516
Women with type 2 diabetes who take glucagon-like peptide-1 (GLP-1) analogues do not have a higher risk of breast cancer than those who take dipeptidyl peptidase-4 (DPP-4) inhibitors, results from a cohort study suggest
However, Medicare reimbursement has historically limited patient access because federal law generally excluded weight-loss medications
Foundayo (Orforglipron) Foundayo, approved in April 2026, is a GLP-1 medication available as a once-daily pill
Coenraad, W
Ozempic is available on NHS prescription for type 2 diabetes according to NICE guidance
US$ 26.00
US$ 29.42
US$ 20.06
US$ 24.60
